SAM Laboratory provides precision diagnostics and partners with several third party institutions to empower better patient care. SAM Laboratory is a wholly owned subsidiary of Clearbridge Health Limited. It is licensed by the Ministry of Health (Singapore) and accredited by the College of American Pathologists (CAP) in 2015. The Laboratory taps into advanced diagnostics technology for patient care, provides comprehensive diagnostic services for precision oncology, and a full range of health screening packages. It also offers the CellSearch CTC test, the only FDA-approved blood test for enumerating circulating tumor cells (CTCs).